BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
Vical, Inc. (NQ: VICL)
3.610 USD  UNCHANGED
Official Closing Price  /  Updated: 8:10 PM EDT, May 20, 2013  /  Add to My Watchlist      
(VICL) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
May 21, 2013
Recent price: 1.74$P/E Ratio: -3 months Target Price: 2.25$ Company DescriptionVical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery... Follow through to the website for more complete reports
(Stock Wizard, 9/22/10)
Vical Inc. (NASDAQ: VICL) tumbled as much as 40% after partner Sanofi-Aventis (NYSE: SNY) announced that late stage trials of NV1FGF failed to meet its goal of preventing limb amputation or...(read more)
(Benzinga, 9/22/10)
Vical Inc (NASDAQ: VICL) dipped 34.97% to $2.51 in the pre-market session. VICL's quarterly revenue dipped 47.84% y/y. Adobe Systems Inc (NASDAQ: ADBE) lost 21.13% to $25.98 in the pre-market session. ADBE has projected...(read more)
Vical (VICL) Company Overview

There is no analysis for VICL yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here